Article
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol.
Systematic reviews - 25 Apr 2020
Semengue Ezechiel Ngoufack Jagni, Santoro Maria Mercedes, Ndze Valantine Ngum, Dambaya Beatrice, Takou Desiré, Teto Georges, Nka Alex Durand, Fabeni Lavinia, Wiyeh Alison, Ceccherini-Silberstein Francesca, Colizzi Vittorio, Perno Carlo-Federico, Fokam Joseph
Abstract excerpt
BACKGROUND: Sub-Saharan Africa carries the greatest burden of HIV-infection with increasing drug resistance burden, which requires improved patient management and monitoring. Current WHO recommendations suggest transitioning to dolutegravir-based (adults) or raltegravir-based-regimens (neonates) for initial antiretroviral therapy (ART) and as a suitable alternative in cases of multi-resistance in resource-limited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
